Free Trial
→ Why Iran May Only Be the First Move (From Behind the Markets) (Ad)tc pixel Free LOGC Stock Alerts

LogicBio Therapeutics (LOGC) Short Interest Ratio & Short Volume

LogicBio Therapeutics logo
$15.03 -0.12 (-0.79%)
As of 11:12 AM Eastern
Compare

LogicBio Therapeutics Short Interest Overview

As of October 15, 2026, LogicBio Therapeutics (LOGC) had a short interest of 520,338 shares sold short, representing 1.98% of the public float. This marks a 2.29% decrease in short interest since the prior report. The short interest ratio (days to cover) is 5.5, meaning it would take 5.5 days of the average trading volume of 133,054 shares to cover all short positions.

Current Short Interest
520,338 shares
Previous Short Interest
532,525 shares
Change Vs. Previous Report
-2.29%
Dollar Volume Sold Short
$8.00 million
Short Interest Ratio
5.5 Days to Cover
Last Record Date
October 15, 2026
Outstanding Shares
45,731,000 shares
Short Percent of Float
1.98%
Today's Trading Volume
37,935 shares
Average Trading Volume
133,054 shares
Today's Volume Vs. Average
29%
Short Selling LogicBio Therapeutics?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for LogicBio Therapeutics and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

LOGC Short Interest Over Time

LOGC Days to Cover Over Time

LOGC Percentage of Float Shorted Over Time

LogicBio Therapeutics Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
10/15/2026520,338 shares $8.00 million -2.3%2.0%5.54 $15.37
9/30/2026532,525 shares $8.08 million +10.6%2.0%1.25 $15.18
9/15/2026481,708 shares $7.03 million -5.2%1.8%2.7 $14.60
8/31/2026507,893 shares $6.55 million -0.4%1.9%2.68 $12.90
8/14/2026510,020 shares $5.70 million -1.2%1.9%1.62 $11.17
7/31/2026516,001 shares $5.00 million +1.8%2.0%3.74 $9.69
7/15/2026506,731 shares $4.64 million -4.1%1.9%7.74 $9.15
6/30/2026528,392 shares $4.64 million -1.0%2.0%1.24 $8.79
6/15/2026533,584 shares $5.18 million -1.0%2.0%2.43 $9.71
5/29/2026539,144 shares $4.84 million -3.2%2.0%1.58 $8.98
5/15/2026556,723 shares $4.80 million -0.2%2.1%5.32 $8.63
4/30/2026557,865 shares $4.75 million -0.3%2.1%3.63 $8.52
4/15/2026559,586 shares $4.90 million -1.3%2.1%4.76 $8.75
3/31/2026567,194 shares $4.57 million -0.2%2.2%3.51 $8.06
3/13/2026568,321 shares $4.55 million +10.2%2.2%0.89 $8.00
2/27/2026515,641 shares $4.11 million -40.2%2.0%1.08 $7.98
1/15/2026904,397 shares $7.14 million +36.4%3.4%2.22 $7.90
12/31/2025662,838 shares $5.01 million +12.0%2.5%0.98 $7.56
12/15/2025591,908 shares $4.79 million +26.9%2.2%0.46 $8.10
11/28/2025466,407 shares $3.53 million -4.8%1.8%5.65 $7.57
10/15/2025610,000 shares $4.73 million -9.9%2.5%4.4 $7.75
9/30/2025677,100 shares $5.41 million -15.2%N/A2.4 $7.99
9/15/2025798,100 shares $6.25 million -8.1%N/A5 $7.83
8/31/2025868,100 shares $6.44 million -7.1%3.6%11.9 $7.42
8/15/2025934,400 shares $6.89 million -10.5%N/A7.2 $7.37
7/31/20251,044,400 shares $7.96 million -6.0%4.3%5.6 $7.62
7/15/20251,110,600 shares $7.94 million -6.0%N/A4.7 $7.15
6/30/20251,181,400 shares $7.86 million -24.0%4.9%1.6 $6.65
6/15/20251,555,300 shares $12.71 million -31.0%6.4%0.6 $8.17
5/31/20252,250,000 shares $18.45 million -2.2%9.5%4.4 $8.20
5/15/20252,300,000 shares $16.95 million -9.8%9.7%6.4 $7.37
4/30/20252,550,000 shares $18.21 million -2.3%10.9%7.5 $7.14
4/15/20252,610,000 shares $17.12 million No Change11.1%7.9 $6.56
3/31/20252,610,000 shares $18.14 million +2.0%11.1%8.7 $6.95
3/15/20252,560,000 shares $19.32 million +1.6%10.9%9 $7.55
2/28/20252,520,000 shares $21.70 million +1.6%10.7%9.1 $8.61
2/15/20252,480,000 shares $19.69 million -2.4%10.6%10 $7.94
1/31/20252,540,000 shares $18.85 million -6.3%10.8%10.9 $7.42
1/15/20252,710,000 shares $17.51 million -0.4%11.5%10.9 $6.46
12/31/20242,720,000 shares $19.26 million -3.2%11.6%10.3 $7.08
Elon's Terrifying Warning: America Is "1,000% Going Bankrupt" (Ad)

The national debt just crossed $39 trillion, and Elon Musk - former head of the Department of Government Efficiency under President Trump - has gone on record saying the U.S. is '1,000% going to go bankrupt' if the trajectory doesn't change. The Trump administration preserved a little-known IRS loophole that allows everyday Americans to shield their retirement savings from the next wave of market turbulence. A free 2027 Wealth Protection Guide walks through the steps to use it.tc pixel

Download your free 2027 Wealth Protection Guide and secure your nest egg
12/15/20242,810,000 shares $21.05 million -5.1%12.0%10.1 $7.49
11/30/20242,960,000 shares $21.16 million -7.2%13.2%10.6 $7.15
11/15/20243,190,000 shares $20.37 million -2.5%14.2%11.9 $6.39
10/31/20243,270,000 shares $21.22 million -0.9%14.2%12.5 $6.49
10/15/20243,300,000 shares $19.44 million +25.0%14.9%11.8 $5.89
9/30/20242,640,000 shares $14.39 million -15.7%12.0%9.5 $5.45
9/15/20243,130,000 shares $16.68 million +20.4%14.2%9.5 $5.33
8/31/20242,600,000 shares $14.04 million -6.1%11.9%7.5 $5.40
8/15/20242,770,000 shares $15.15 million +14.0%12.7%7.3 $5.47
7/31/20242,430,000 shares $13.12 million -33.8%12.0%5.8 $5.40
7/15/20243,670,000 shares $22.39 million No Change18.1%6.9 $6.10
10/31/2022274,400 shares $562.52 thousand +104.9%1.3%0.5 $2.05
10/15/2022133,900 shares $274.50 thousand +159.5%0.7%0.3 $2.05
9/30/202251,600 shares $14.06 thousand +77.3%0.3%0.1 $0.27
9/15/202229,100 shares $10.91 thousand -61.1%0.2%0.2 $0.38
8/31/202274,800 shares $26.81 thousand -2.7%0.4%0.4 $0.36
8/15/202276,900 shares $39.60 thousand +18.7%0.4%0.3 $0.52
7/31/202264,800 shares $25.43 thousand -8.7%0.4%0.1 $0.39
7/15/202271,000 shares $27.69 thousand +110.7%0.4%0.1 $0.39
6/30/202233,700 shares $11.80 thousand -75.8%0.2%0 $0.35
6/15/2022139,100 shares $60.51 thousand -37.6%0.8%0.1 $0.44
5/31/2022222,800 shares $111.40 thousand -57.6%1.2%0.2 $0.50
5/15/2022526,000 shares $226.18 thousand +952.0%2.9%0.4 $0.43
4/30/202250,000 shares $22 thousand -60.9%0.3%0 $0.44
4/15/2022127,800 shares $86.14 thousand -0.1%0.7%0.4 $0.67
3/31/2022127,900 shares $86.98 thousand -10.0%0.7%0.4 $0.68
3/15/2022142,100 shares $99.19 thousand -11.9%0.8%0.4 $0.70
2/28/2022161,200 shares $106.39 thousand -39.3%0.9%0.5 $0.66
2/15/2022265,500 shares $196.47 thousand +60.0%1.5%0.9 $0.74
1/31/2022165,900 shares $248.85 thousand -5.8%0.9%0.6 $1.50
1/15/2022176,100 shares $343.40 thousand -4.3%1.4%1.9 $1.95
12/31/2021184,000 shares $425.04 thousand -31.6%1.4%1.9 $2.31
12/15/2021268,800 shares $658.56 thousand -55.0%2.1%2.8 $2.45
11/30/2021597,600 shares $1.79 million -0.5%4.8%7.5 $3.00
11/15/2021600,300 shares $2.11 million -0.7%4.8%7.4 $3.52

LOGC Short Interest - Frequently Asked Questions

Short interest is the volume of LogicBio Therapeutics shares that have been sold short but have not yet been closed out or covered. As of October 15th, traders have sold 520,338 shares of LOGC short. 1.98% of LogicBio Therapeutics' shares are currently sold short. Learn More on LogicBio Therapeutics' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. LOGC shares currently have a short interest ratio of 5.5. Learn More on LogicBio Therapeutics's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.98% of LogicBio Therapeutics' floating shares are currently sold short.

LogicBio Therapeutics saw a drop in short interest since the prior report. As of October 15th, there was short interest totaling 520,338 shares, a drop of 2.3% from the previous total of 532,525 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

1.98% of LogicBio Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "biotechnology" compare to LogicBio Therapeutics: Viridian Therapeutics, Inc. (16.28%), ADMA Biologics Inc (9.07%), Zai Lab Limited Unsponsored ADR (8.17%), Biohaven Ltd. (13.75%), NewAmsterdam Pharma Company N.V. (13.53%), Precigen, Inc. (22.21%), Arcus Biosciences, Inc. (10.50%), Zealand Pharma A/S (0.96%), Celldex Therapeutics, Inc. (12.89%), Aurinia Pharmaceuticals Inc (6.53%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($71.77 billion), Invesco QQQ ($59.70 billion), iShares Russell 2000 ETF ($23.54 billion), Medtronic PLC ($13.33 billion), SPDR S&P Biotech ETF ($10.47 billion), iShares iBoxx $ High Yield Corporate Bond ETF ($10.36 billion), Nebius Group N.V. ($8.98 billion), iShares 20+ Year Treasury Bond ETF ($8.92 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($8.10 billion), and iShares Semiconductor ETF ($7.74 billion). View all of the most shorted stocks.

Short selling LOGC is an investing strategy that aims to generate trading profit from LogicBio Therapeutics as its price is falling. LOGC shares are trading down $0.12 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for LogicBio Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of LOGC, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including LOGC, twice per month. The most recent reporting period available is October, 15 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like LOGC:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.


Related Companies
Short Interest Tools

Short interest data for OTCMKTS:LOGC is sourced from the Financial Industry Regulatory Authority (FINRA), with the most recent report published on 10/26/2026. FINRA publishes updated short interest twice a month.
From Our Partners
Trump’s EO to send this $5 stock ripping higher…?
President Trump's December executive order declared space a national security and economic priority, fueling a...
Traders Agency | Sponsoredtc pixel
One bank just ran the numbers on gold for the next 5 years
Deutsche Bank's research team just modeled where gold could land by 2031 if central banks keep shifting reserv...
Cedar Gold Group | Sponsoredtc pixel
Today's free pick (on me)
Elon Musk doesn't own the chip inside every Tesla, Starlink dish, and AI satellite - he licenses it from one l...
Behind the Markets | Sponsoredtc pixel
Elon's Terrifying Warning: America Is "1,000% Going Bankrupt"
The national debt just crossed $39 trillion, and Elon Musk - former head of the Department of Government Effic...
American Hartford Gold | Sponsoredtc pixel
The investigation Porter spent tens of thousands to document
Porter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...
Porter & Company | Sponsoredtc pixel
Uranium Mine Flood That Sparked a 2006 Price Surge Returns
In 2006, a flooded mine at Cigar Lake sent uranium prices from the $50 range to $136 in eight months. This pa...
Digest Publishing | Sponsoredtc pixel
My public warning after 55 years of watching the markets
Dr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each war...
Weiss Ratings | Sponsoredtc pixel
Last call for your free 0DTE report
The 0DTE Game Plan lays out a simple 3-step framework for trading same-day options: Plan it, profit from it, p...
Profits Run | Sponsoredtc pixel